申请人:Duke University
公开号:US10000469B2
公开(公告)日:2018-06-19
Inducible HSP70 is overexpressed in a wide spectrum of human tumors and its expression correlates with metastasis and poor outcomes to radiation and chemotherapy in patients. Identification of small molecule inhibitors of HSP70 pose a new therapy to cancer treatment. HS72, a benzimidazole piperidinyl carboxamide has been identified as an allosteric inhibitor for HSP70 and has demonstrated good tumor growth inhibition in vivo.
诱导型 HSP70 在多种人类肿瘤中过度表达,其表达与肿瘤转移以及患者对放疗和化疗的不良反应有关。HSP70 小分子抑制剂的发现为癌症治疗提供了一种新疗法。HS72是一种苯并咪唑哌啶羧酰胺,已被确定为HSP70的异构抑制剂,并在体内显示出良好的肿瘤生长抑制作用。